Showing results (111-120 of 168) with videos related to

Sort By:
Pageof 17
European Urology|April 18, 2020
Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic NeoplasmsStephanie L Skala, Xiaoming Wang, Yuping Zhang, et al.
Oncotarget|August 14, 2014
The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progressionBalabhadrapatruni V S K Chakravarthi, Satya Sreehari Pathi, Moloy T Goswami, et al.
Cancer Research|July 1, 2010
Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cellsLiqun Chen, Salma Siddiqui, Swagata Bose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2021
A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate CancerPhillip L Palmbos, Stephanie Daignault-Newton, Scott A Tomlins, et al.
Prostate Cancer and Prostatic Diseases|December 30, 2022
MyProstateScore in men considering repeat biopsy: validation of a simple testing approachJeffrey J Tosoian, Michael S Sessine, Bruce J Trock, et al.
The Journal of Biological Chemistry|May 7, 2020
The role of the histone H3 variant CENPA in prostate cancerAnjan K Saha, Rafael Contreras-Galindo, Yashar S Niknafs, et al.
Neoplasia (New York, N.Y.)|August 28, 2016
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate CancerSudhanshu Shukla, Xiang Zhang, Yashar S Niknafs, et al.
Urology|August 11, 2020
Impact of the MyProstateScore (MPS) Test on the Clinical Decision to Undergo Prostate Biopsy: Results From a Contemporary Academic PracticeAmir H Lebastchi, Christopher M Russell, Yashar S Niknafs, et al.
The Journal of Urology|February 28, 2016
Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and RecurrenceAdam I Cole, Todd M Morgan, Daniel E Spratt, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2022
Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsyStefan E Eng, Benjamin Basasie, Alfonso Lam, et al.
Pageof 17